149 related articles for article (PubMed ID: 5577313)
21. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
Novikov DK
Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
[No Abstract] [Full Text] [Related]
22. Lowering of the tumoricide activity of human serum with Varidase. II. Antibodies against Varidase in human serum measured by complement binding.
Mikolásek J
Neoplasma; 1975; 22(3):279-84. PubMed ID: 1099470
[TBL] [Abstract][Full Text] [Related]
23. The effect of antiserum fractions on Ehrlich ascites tumour cells.
Wang M
Br J Cancer; 1971 Jun; 25(2):315-22. PubMed ID: 5115831
[TBL] [Abstract][Full Text] [Related]
24. Immunological studies on Yoshida sarcoma cells. I. The effect of heterologous anti-Yoshida sarcoma cell antibodies on the lysosomal acid DNase of sarcoma cells.
Kuroyanagi T; Sugiyama H
Jpn J Exp Med; 1970 Jun; 40(3):183-90. PubMed ID: 5312120
[No Abstract] [Full Text] [Related]
25. Host resistance against tumor and its synergic effect with cancer chemotherapy.
Sato R
Gan; 1967 Jun; 58(3):211-20. PubMed ID: 6081225
[No Abstract] [Full Text] [Related]
26. [On the tumor-inhibiting effects of components of ground substance. VI. Comparative studies on the effects of glucosamine on the metabolism of Yoshida rat and Ehrlich mouse ascites tumors].
VOSS H; BECKER K; LINDNER J
Z Krebsforsch; 1963 Feb; 65():228-40. PubMed ID: 14010458
[No Abstract] [Full Text] [Related]
27. Effect of withaferin A on ehrlich ascites tumor cells. II. Target tumor cell destruction in vivo by immune activation.
Shohat B; Joshua H
Int J Cancer; 1971 Nov; 8(3):487-96. PubMed ID: 5002873
[No Abstract] [Full Text] [Related]
28. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice.
Sheeja K; Kuttan G
Integr Cancer Ther; 2007 Mar; 6(1):66-73. PubMed ID: 17351028
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy of Ehrlich ascites carcinoma (EAC) with antiserum to modified EAC.
Das AK; Roy DK
Indian J Exp Biol; 1985 Nov; 23(11):641-3. PubMed ID: 3833682
[No Abstract] [Full Text] [Related]
30. ["Immunochemical endgrouping" with Helix agglutinins of ascites tumor cells. Comparison with the blood cells of animals].
Prokop O; Graffi A; Schnitzler S
Acta Biol Med Ger; 1968; 20(3):Suppl:K9-K15. PubMed ID: 4302202
[No Abstract] [Full Text] [Related]
31. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
Sethi KK; Brandis H
Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
[No Abstract] [Full Text] [Related]
32. Antigens of the surface of mouse ascites tumour cells. I. Studies with rabbit anti-mouse cell sera.
Boyle W; Davies DA
Immunology; 1966 Oct; 11(4):353-9. PubMed ID: 5924620
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of Herpesvirus hominis infections with the use of Ehrlich mouse ascites tumour cells.
Wutzler P; Sauerbrei A; Sprössig M; Färber I; Schweizer H
Acta Virol; 1980 Mar; 24(2):132-6. PubMed ID: 6107021
[TBL] [Abstract][Full Text] [Related]
34. Experimental biotherapy by leptospiral infection. VII. Quantitative titration of the tumoricidal effect of leptospirae by means of 51Cr labelled target cells of mouse ascites tumours.
Oravec C; Cambelová J; Kmety E
Neoplasma; 1972; 19(6):639-52. PubMed ID: 4670380
[No Abstract] [Full Text] [Related]
35. Surface antigen on Ehrlich ascites tumor cells.
Pessina A; Brambilla P; Mocarelli P
Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
[TBL] [Abstract][Full Text] [Related]
36. [Labeling of NK/Ly ascites tumor cells with Cr51 and its application in immunolytic experiments].
Toperczer J; Elek G
Nucl Med (Stuttg); 1965 Dec; 5(1):12-20. PubMed ID: 5868781
[No Abstract] [Full Text] [Related]
37. [Stimulation of DPN metabolic processes in ascites tumors by low dosage roentgen irradiation and trenimon].
Rüter J; Vachek H; Oldekop M; Wüppen I; Hilz H
Biochem Z; 1966 Mar; 344(2):153-66. PubMed ID: 4293039
[No Abstract] [Full Text] [Related]
38. [Histochemical studies on the effect of antibody and serum factors on ascites tumor cells and mast cells].
Keller R
Bibl Haematol; 1967; 27():95-101. PubMed ID: 4233209
[No Abstract] [Full Text] [Related]
39. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
40. [Simple storage of Ehrlich ascites tumor cells].
Hilz H; Jarmers G
Z Krebsforsch; 1969; 72(4):341-2. PubMed ID: 4242672
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
